Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation
Tingting Zou, Cheng Zeng, Junyan Qu, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1143-1143
Open Access | Times Cited: 15

Showing 15 citing articles:

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
Lei Zhang, Biwei Ye, Zhuo Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 982-997
Open Access | Times Cited: 56
Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 30
Natural products reverse cancer multidrug resistance
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 14
Natural quinazolinones: From a treasure house to promising anticancer leads
Hanbing Li, Gaohang Fu, Weihui Zhong
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114915-114915
Closed Access | Times Cited: 23
Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin
Yi Li, Anqi Wu, Lin Chen, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Comprehensive Analysis of 11 Species of Euodia (Rutaceae) by Untargeted LC-IT-TOF/MS Metabolomics and In Vitro Functional Methods
Xuhong Yong, Wang Bi, Mengdi Wang, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1059-1059
Open Access | Times Cited: 4
miR-603 Mediates Thyroid Cancer Progression by Inhibiting HACE1-Dependent YAP1 Degradation
Tangya Li, Jian Chu, Zhou Guangjun, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110453-110453
Closed Access
Synthesis of Quinazolinone-Fused Tetrahydroisoquinolines and Related Polycyclic Scaffolds by Iodine-Mediated sp3 C–H Amination
Manman Wang, Wenjun Ye, Nannan Sun, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 2, pp. 1061-1074
Closed Access | Times Cited: 7
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Major Indole Alkaloids in Evodia Rutaecarpa: The Latest Insights and Review of Their Impact on Gastrointestinal Diseases
Liulin Chen, Yu Hu, Zhen Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115495-115495
Open Access | Times Cited: 6
Reversal of P‐glycoprotein‐mediated multidrug resistance by natural N‐alkylated indole alkaloid derivatives in KB‐ChR‐8‐5 drug‐resistant cancer cells
Pradhapsingh Bharathiraja, David Cardoso, N. Rajendra Prasad, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 9
Closed Access | Times Cited: 5
Network pharmacology-based screening of the active ingredients and mechanisms of evodiae fructus anti-glioblastoma multiforme
Gang Wu, Qingpei Hao, Bo Liu, et al.
Medicine (2022) Vol. 101, Iss. 39, pp. e30853-e30853
Open Access | Times Cited: 4
Influence of <i>GPRC5A</i>-Regulated <i>ABCB1</i> Expression on Lung Adenocarcinoma Proliferation
Yun Li, Wenwen Cui, Zhongfa Yang, et al.
Chinese Medical Sciences Journal (2024) Vol. 39, Iss. 1, pp. 9-18
Open Access
Role of MARCH E3 ubiquitin ligases in cancer development
Abhayananda Behera, Deepanshi Sachan, Ganesh Kumar Barik, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1257-1277
Closed Access
Rutaecarpine prevents the malignant biological properties of breast cancer cells by the miR-149-3p/S100A4 axis
Yi Xiong, Chao Xiong, Peng Li, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 17, pp. 930-930
Open Access | Times Cited: 1
Special Issue: Resistance to Targeted Therapies in Human Cancer
Tae‐Won Lee, Hee‐Joo Choi, Kyung‐min Lee, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 414-414
Open Access
Page 1

Scroll to top